Key result
Malignant hypertension remains a significant clinical challenge in patient management and treatment.
Key points are not available for this paper at this time.
Heightens need for vigilant monitoring in practice; leaves open the need for targeted trials to improve outcomes.
J J Beutler, H A Koomans; Malignant hypertension: still a challenge., Nephrology Dialysis Transplantation, Volume 12, Issue 9, 1 September 1997, Pages 2019–2023
No takes yet. Share an insight, caveat, or question.
Beutler et al. (1997) studied this question. Malignant hypertension remains a significant clinical challenge in patient management and treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: